<DOC>
	<DOCNO>NCT00688857</DOCNO>
	<brief_summary>This single-center , randomize , open-label , multi-dose crossover study assess pharmacokinetic profile diazoxide choline coat versus uncoated formulation healthy volunteer . The primary objective compare pharmacokinetic ( PK ) profile diazoxide choline controlled-release coat tablet versus uncoated tablet healthy volunteer feed condition . Secondary objective assess diazoxide choline pharmacokinetic ( PK ) parameter fast condition , ass safety tolerability diazoxide choline controlled-release coat tablet versus uncoated tablet healthy volunteer .</brief_summary>
	<brief_title>Open-label Pharmacokinetic Study Diazoxide Choline Coated vs. Uncoated Formulations</brief_title>
	<detailed_description />
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<mesh_term>Choline</mesh_term>
	<mesh_term>Diazoxide</mesh_term>
	<criteria>Signed informed consent Healthy male female subject 18 75 year age Body mass index ( BMI ) 2235 kg/m2 Fasting glucose ≤ 125 mg/dL HbA1C ≤ 6.5 . Fasting triglyceride ≥100 mg/dL ≤ 500 mg/dL Not pregnant Significant underlie medical condition Clinical laboratory test value outside accepted range Smokers , tobacco user , subject currently use nicotine product Substance abuse History allergic response ( ) diazoxide relate drug Recent significant weight loss Use medication affect body weight , lipid glucose metabolism Unable comply study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>